FTP058

Nom de l'organisation

Labomar S.p.A.

SRN

IT-MF-000007965

Statut du fabricant

Actif

Santé des certificats sur le portefeuille de ce fabricant.

1 avertissement enregistré — faire défiler le panneau pour tout voir.

• CW999

  Do not take if you are allergic or hypersensitive to any component. Do not use the product after the expiry date printed on the package. Do not administer to children. The expiry date refers to the product in intact package, properly stored. Even if no side effects are known, it is recommended not to use the product during pregnancy or while breastfeeding. In any case, consult your doctor. In case of concomitant drug therapy, consult your doctor before taking it, as the device may delay or reduce the absorption of drugs administered orally. It is therefore recommended to consult the doctor in case of simultaneous intake of oral medicines which must, in any case, be administered at a distance of at least 2 hours. Consult the doctor if an improvement in clinical status is not noted during the tratment period. Do not use in case the package is not intact. Keep out of reach of children

Marché principal en Italie ; disponible dans 1 pays au total.

Dénomination commerciale

non renseigné

Code d'UDI-DI

D-FTP058_2KK

Basic UDI-DI

B-FTP058_2KK

Numéro de référence/catalogue

FTP058

Entité d'attribution

EUDAMED

Catégorie de risque

Classe IIb

Législation applicable

MDD [Directive 93/42/CEE relative aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

Lafarmacia. Acidità e Reflusso is a medical device for the treatment of symptoms related to non-specific dyspepsia and gastroesophageal reflux, such as acid regurgitation, retrosternal burning, gastric heartburn.

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• G0401ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS